CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Bevacizumab decreases vestibular schwannomas growth rate in children and teenagers with neurofibromatosis type 2
Author
Andre Nicolas
Baroncini Marc
+11Â more
Bonne Nicolas Xavier
Dubrulle Frédérique,
Gaillard Vianney
Hochart Audrey
Leblond Pierre
Lejeune Jean-Paul
Nève Véronique
Sudour Bonnange Héléne
Vannier Jean-Pierre
Vincent Christophe
Vinchon Matthieu
Publication venue
'Springer Science and Business Media LLC'
Publication date
29/05/2015
Field of study
No full text
International audienc
HAL - Normandie Université
HAL - Université de Franche-Comté
Crossref
HAL AMU
HAL Descartes
Bevacizumab decreases vestibular schwannomas growth rate in children and teenagers with neurofibromatosis type 2
Author
A Jacob
Audrey Hochart
+33Â more
Christophe Vincent
D Mathieu
DGR Evans
Frederique Dubrulle
GJ Harris
Héléne Sudour Bonnange
Jean-Paul Lejeune
Jean-Pierre Vannier
JO Blakeley
KM Slusarz
M Giovannini
MA Karajannis
MA Karajannis
Marc Baroncini
Matthieu Vinchon
ME Baser
ML Bush
Nicolas André
Nicolas Xavier Bonne
P Cayé-Thomasen
Pierre Leblond
S Ammoun
SR Plotkin
SR Plotkin
SR Plotkin
SR Plotkin
SS Shord
T Uesaka
V Subbiah
V-F Mautner
Vianney Gaillard
Véronique Nève
WH Slattery
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref